Prevention Cardiology

Nanda Nanda; Yusfa Chairunnisa

doi:10.29103/jkkmm.v3i6.19142

Prevention Cardiology

Nanda Nanda, Yusfa Chairunnisa

Abstract

Penyakit kardiovaskular masih menjadi masalah kesehatan di Indonesia saat ini. Hal ini dapat meningkatkan angka kesakitan, kecacatan, dan beban sosial ekonomi masyarakat. Indikator utama penyakit kardiovaskular adalah kualitas hidup seseorang. Oleh karena itu, diperlukan deteksi dini dan tindakan pencegahan terkait risiko penyakit kardiovaskular agar dapat dipelajari lebih lanjut, dipantau, dan diberikan intervensi yang tepat oleh tenaga kesehatan. Dalam upaya untuk mengendalikan faktor risiko tersebut, Asosiasi Jantung Amerika (American Heart Association) memberikan definisi kesehatan kardiovaskular yang ideal menggunakan 7 metrik yang disebut "Life's Simple 7", yang terdiri dari tidak merokok, berat badan (BB) yang sehat, aktivitas fisik yang cukup dan diet seimbang, serta mencapai nilai target untuk kolesterol, tekanan darah (TD), dan glukosa darah.

Keywords

Penyakit kardiovaskular, deteksi dini, Asosiasi Jantung Amerika

Full Text:

PDF

References

Setiadi AP, Halim SV. Penyakit Kardiovaskular; Seri Pengobatan Rasional. Pertama. Yogyakarta: Graha Ilmu; 2018. 1–14 p.

World Health Organization. Cardiovascular diseases (CVDs) [Internet]. WHO. 2021 [cited 2022 Oct 24]. Available from: https://www.who.int/health-topics/cardiovascular-diseases

Negeriku RS. Penyakit Jantung Koroner Didominasi Masyarakat Kota [Internet]. Kementerian Kesehatan. 2021 [cited 2022 Oct 24]. Available from: https://sehatnegeriku.kemkes.go.id/baca/umum/20210927/5638626/penyakit-jantung-koroner-didominasi-masyarakat-kota/

Cardiology AC of. ASCVD Risk Estimator [Internet]. [dikutip 23 Oktober 2022]. Tersedia pada: https://tools.acc.org/ldl/ascvd_risk_estimator/index.html#!/calulate/estimator/

Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Vol. 140, Circulation. 2019. 596–646 hal.

Abdulhamied Alfaddagh, Kelly Arps, Roger S. Blumenthal SSM. The ABCs of Primary Cardiovascular Prevention: 2019. American College of Cardiology. https://www.acc.org/latest-in-cardiology/articles/2019/03/21/14/39/abcs-of-primary-cv-prevention-2019-update-gl-prevention

Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet. 2018;392(10152):1036–46.

Lilly leonard S. Pathophysiology of Heart Disease. 6th Editio. Vol. 64, Harvard Medical School. Wolters Kluwer; 2016. 910–910 hal.

Rilantono LI. Penyakit kardiovaskular (PKV) : 5 rahasia. Edisi Pert. Anna Ulfah Rahajoe SK-K, editor. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2018.

Visseren FLJ, MacH F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337.

Halvorsen S, Andreotti F, Ten Berg JM, Cattaneo M, Coccheri S, Marchioli R, et al. Aspirin therapy in primary cardiovascular disease prevention: A position paper of the european society of cardiology working group on thrombosis. J Am Coll Cardiol. 2014;64(3):319–27.

McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, et al. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018;379(16):1509–18

Whelton PK, Kumanyika SK, Cook NR, et al.Efficacy of nonpharmacologic interventions in adultswith high-normal blood pressure: results from phase 1of the Trials of Hypertension Prevention. Trials ofHypertension Prevention Collaborative ResearchGroup. Am J Clin Nutr. 1997;65:652

Neter JE, Stam BE, Kok FJ, et al. Influenceofweight reduction on blood pressure: a meta-analysis ofrandomized controlled trials. Hypertension. 2003;42:878

Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium andthe Dietary Approaches to Stop Hypertension (DASH)diet. DASH-Sodium Collaborative Research Group.N Engl J Med. 2001;344:3–10

Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns onblood pressure. DASH Collaborative Research Group.N Engl J Med. 1997;336:1117–24

Sundström J, Arima H, Jackson R, et al. Ef-fects of blood pressure reduction in mild hypertension:a systematic review and meta-analysis. Ann InternMed. 2015;162:184.

Xie X, Atkins E, Lv J, et al. Effects of intensiveblood pressure lowering on cardiovascular and renaloutcomes: updated systematic review and meta-anal-ysis. Lancet. 2016;387:435.

PERKI. Pedoman Tatalksana Dislipidemia.; 2013. doi:10.1136/bcr.09.2008.0970

Puspaseruni K. Tatalaksana Dislipidemia terkait Penyakit Kardiovaskular Aterosklerosis (ASCVD): Fokus pada Penurunan LDL-c. Cermin Dunia Kedokt. 2021;48(10):395. doi:10.55175/cdk.v48i10.1512

World Health Organization. Who Report On The Global Tobacco Epidemic, 2019: Offer help to quit tobacco use. Tob Control [Internet]. 2019; Tersedia pada: https://apps.who.int/iris/bitstream/handle/10665/325968/WHO-NMH-PND-2019.5-eng.pdf?ua=1

Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate KH, et al. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: A systematic analysis from the global burden of disease study 2015. Lancet. 2017;389(10082):1885–906.

D’Amario D, Migliaro S, Borovac JA, Vergallo R, Galli M, Restivo A, et al. Electronic cigarettes and cardiovascular risk: Caution waiting for evidence. Eur Cardiol Rev . 2019;14(3):151–8.

Kemenkes RI. Profil Kesehatan Indonesia. Jakarta: Kemenkes RI; 2021. Kementrian Kesehatan Republik Indonesia.

American Diabetes Association: Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010; 28(S1): S37-S42

Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care.2004; 27:1047–1053.

Lobelo F, Rohm Young D, Sallis R, Garber MD, Billinger SA, Duperly J, et al. Routine Assessment and Promotion of Physical Activity in Healthcare Settings: A Scientific Statement From the American Heart Association. Circulation. 2018;137(18):e495–522

DOI: https://doi.org/10.29103/jkkmm.v3i6.19142